These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3619983)

  • 21. Antithrombotic effects of 3-([1:1',2':1"]-3'-terphenyl)propanol in animals.
    Hongou K; Miyamae T; Hashizume H; Oshima K; Ogawa T; Hongou T; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Oct; 47(10):1104-8. PubMed ID: 9368702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of pharmacological data on benzydamine.
    Cioli V; Corradino C; Scorza Barcellona P
    Int J Tissue React; 1985; 7(3):205-13. PubMed ID: 3899969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats.
    Qu YZ; Li XX
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
    Bruseghini L; Vilageliu J; Freixes J
    Arzneimittelforschung; 1981; 31(10a):1790-5. PubMed ID: 6797443
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposite effect of lysine on platelet aggregation induced by arachidonate and by other aggregants.
    Ts'ao C; Hart SJ; Krajewski DV; Sorensen PG
    Thromb Haemost; 1982 Aug; 48(1):78-83. PubMed ID: 6813998
    [No Abstract]   [Full Text] [Related]  

  • 26. Nonpeptide glycoprotein IIb/IIIa inhibitors. 15. Antithrombotic efficacy of L-738,167, a long-acting GPIIb/IIIa antagonist, correlates with inhibition of adenosine diphosphate-induced platelet aggregation but not with bleeding time prolongation.
    Cook JJ; Sitko GR; Holahan MA; Stranieri MT; Glass JD; Askew BC; McIntyre CJ; Claremon DA; Baldwin JJ; Hartman GD; Gould RJ; Lynch JJ
    J Pharmacol Exp Ther; 1997 May; 281(2):677-89. PubMed ID: 9152373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of procainamide on pulmonary thromboembolism and platelet malondialdehyde in mice.
    Pang JX; Sun LS; Wang XY; Yang SQ; Shan CW
    Zhongguo Yao Li Xue Bao; 1996 Nov; 17(6):500-2. PubMed ID: 9863141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of methylprednisolone and hydrocortisone on aggregation of rabbit platelets induced by arachidonic acid and other aggregating substances.
    Glass F; Lippton H; Kadowitz PJ
    Thromb Haemost; 1981 Dec; 46(4):676-9. PubMed ID: 6800048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nitric oxide and prostacyclin are involved in antithrombotic action of captopril in venous thrombosis in rats.
    Pawlak R; Chabielska E; Golatowski J; Azzadin A; Buczko W
    Thromb Haemost; 1998 Jun; 79(6):1208-12. PubMed ID: 9657449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antithrombotic activity of BAY g 6575.
    Seuter F; Busse WD; Meng K; Hoffmeister F; Möller E; Horstmann H
    Arzneimittelforschung; 1979; 29(1):54-9. PubMed ID: 375948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiplatelet and antithrombotic activity of SL65.0472, a mixed 5-HT1B/5-HT2A receptor antagonist.
    Berry CN; Lorrain J; Lochot S; Delahaye M; Lalé A; Savi P; Lechaire I; Ferrari P; Bernat A; Schaeffer P; Janiak P; Duval N; Grosset A; Herbert JM; O'Connor SE
    Thromb Haemost; 2001 Mar; 85(3):521-8. PubMed ID: 11307825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of glycoprotein IIb/IIIa mediates the antithrombotic activity of butanol fraction of Actinostemma lobatum Maxim.
    Kim KH; Lee HJ; Lee JH; Jang YS; Kim DK; Shim BS; Cho KH; Ko SG; Ahn KS; Kim SH
    J Ethnopharmacol; 2008 Mar; 116(3):431-8. PubMed ID: 18243609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical and pharmacological effects of dipyrone and its metabolites in model systems related to arachidonic acid cascade.
    Weithmann KU; Alpermann HG
    Arzneimittelforschung; 1985; 35(6):947-52. PubMed ID: 3927930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aggregation and inhibition of rat platelets, and the formation of endoperoxide metabolites.
    Hwang DH
    Prostaglandins Med; 1980 Sep; 5(3):163-73. PubMed ID: 7413850
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antithrombotic effects of the novel inhibitor of thrombin-induced offtelet aggregation and thrombus formation, 3-[2-[1,1':2',1"]-terphenyl-4'-yl)ethyl]phenoxyacetic acid.
    Miyamae T; Hashizume H; Ogawa T; Okayama T; Nukui E; Oshima K; Morikawa T; Hagiwara M
    Arzneimittelforschung; 1997 Jan; 47(1):13-8. PubMed ID: 9037437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS; Bruttger O; Pally C; Hagenbach A
    Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro investigation on the antiaggregating activity of ditazole.
    Prisco D; Favilla S; Fortini A; Gensini GF
    Int J Clin Pharmacol Res; 1984; 4(5):341-7. PubMed ID: 6151552
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Inhibiting action of anti-arrhythmia agents of the phenothiazine series--etmozin and its diethylamino analog--on platelet aggregation and metabolism of endogenous arachidonic acid].
    Mazurov AV; Leĭtin VL; Repin VS; Rozenshtraukh LV; Smirnov VN
    Biull Eksp Biol Med; 1984 Jan; 97(1):63-5. PubMed ID: 6419795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New orally active non-peptide fibrinogen receptor (GpIIb-IIIa) antagonists: identification of ethyl 3-[N-[4-[4-[amino[(ethoxycarbonyl) imino]methyl]phenyl]-1,3-thiazol-2-yl]-N-[1-[(ethoxycarbonyl)methyl]pip erid -4-yl]amino]propionate (SR 121787) as a potent and long-acting antithrombotic agent.
    Badorc A; Bordes MF; de Cointet P; Savi P; Bernat A; Lalé A; Petitou M; Maffrand JP; Herbert JM
    J Med Chem; 1997 Oct; 40(21):3393-401. PubMed ID: 9341914
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.